[ sulge aken ]

Elulookirjeldus (CV)
1.Eesnimi Külli
2.Perekonnanimi Kingo
3.Töökoht SA TÜK Nahahaiguste Kliinik, TÜ Nahahaiguste Kliinik, Raja 31, Tartu 50405, Eesti
4.Ametikoht arst-õppejõud; teadur
5.Sünniaeg 07.04.1972 (päev.kuu.aasta)
6.Haridus 1978 – 1990 Tartu 10. Keskkool
1990 – 1996 Tartu Ülikool, arstiteaduskond (cum laude)
1997 – 2001 Tartu Ülikool, residentuur dermatoveneroloogia erialal
2001 – 2005 Tartu Ülikool, doktorantuur dermatoveneroloogia erialal
7.Teenistuskäik 2001 – SA TÜK Nahahaiguste Kliinik, arst-õppejõud
2004 – TÜ Nahahaiguste Kliiniku teadur
8.Teaduskraad Ph.D.
9.Teaduskraadi välja
andnud asutus, aasta		 Tartu Ülikool, arstiteaduskond, 10.06.2005
10.Tunnustused 1. I preemia Eesti üliõpilaste teadustööde 2004. a riiklikul konkursil arstiteaduste valdkonnas teadustöö "Interleukiin-10 ja Interleukiin-20 geenide ühenukleotiidsete polümorfismide seosed psoriaasiga" eest, 10.12.2004.
2. Tartu Ülikooli Kliinikumi teadustööpreemia uurimustöö "Interleukiin-20 geneetiliste polümorfismide seos psoriaasiga" eest, 11.10.2003.
3. Molekulaarse ja Kliinilise Meditsiini Keskuse 2003 a. doktorandipreemia uurimustöö "Interleukiin-20 geneetiliste polümorfismide seos psoriaasiga" eest.
11.Teadusorganisatsiooniline
ja –administratiivne
tegevus		 1. Eesti Naha- ja Suguhaiguste Arstide Seltsi liige
2. Sugulisel Teel Levivate Infektsioonide Eesti Ühingu liige
3. Balti Dermatoveneroloogide Seltsi liige
4. Ida-Euroopa Dermatoveneroloogide Seltsi liige
12.Juhendamisel kaitstud
väitekirjad
13.Teadustöö põhisuunad Interleukiin-10 (IL-10) ja tema perekonda kuuluvate tsütokiinide interleukiin-19 (IL-19), interleukiin-20 (IL-20) ja interleukiin-24 (IL-24) geneetilisite polümorfismide ja nende seoste uurimine erinevate krooniliste dermatoosidega.
14.Jooksvad grandid ETF grant nr. 5712: Interleukiin-10 perekonna tsütokiinide geenide polümorfismi seosed psoriaasiga.

Sihtfinantseerimine, 0182128s02 (TARNH2128): Naha- ja suguhaiguste patogeneesi molekulaarsed mehhanismid ja epidemioloogilised aspektid Eestis.
15.Teaduspublikatsioonid

Kingo K, Rätsep R, Kõks S, Karelson M, Silm H, Vasar E. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. Journal of Dermatological Science (2005) 37, 111-113.

Kingo K, Rätsep R, Kõks S, Karelson M, Silm H, Vasar E. The potential functional influence of polymorphisms of IL-20 gene in plaque psoriasis. JEADV 2005; accepted 18.07.2005.

Kõks S, Kingo K, Vabrit K et al. Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes and Immunity (2005) 6, 407-415.

Mossner R, Kingo K, Kleensang A et al. Association of TNF -238 and -308 Promoter Polymorphisms with Psoriasis Vulgaris and Psoriatic Arthritis but not with Pustulosis Palmoplantaris. J Invest Dermatol. (2005) 124, 282-284.

S. Kõks, K. Kingo, E. Vasar, H. Silm “Interleukin-19 subfamily of cytokines”, peatükk raamatus “Cytokine gene polymorphisms in multifactorial conditions”. CRC Press, ilmub 2006.

S. Kõks, K. Kingo, E. Vasar, H. Silm “Psoriasis and cytokine polymorphisms”, peatükk raamatus “Cytokine gene polymorphisms in multifactorial conditions”. CRC Press, ilmub 2006.

Kingo K, Kõks S, Nikopensius T, Silm H, Vasar E. Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes and Immunity (2004) 5, 117-121.

Kingo K. Psoriaas ja geenid. Moodne Meditsiin 2004 (nov); 18-19

Kingo K, Rätsep R, Kõks S, Karelson M, Silm H, Vasar E. Genetic influence on IL-10 expression of patients with plaque type psoriasis. JEADV 2004; 18(Sppl 2): 337.

Kõks S, Kingo K, Rätsep R, Karelson M, Silm H, Vasar E. Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes and Immunity (2004) 5, 662–667.

Karelson M, Kürsa V., Kingo K, Silm H Teleangiectasia macularis eruptiva perstans. Proceedings of the 11th Congress of the European Academy of Dermatology and Venereology- Bologne, M.N.L. Scientific Publishing & Communication. 2003; 93-95.

Kingo K, Kõks S, Karelson M, Silm H, Vasar E. Promoter polymorphism at position-592 of the interleukin-10 is not associated with early- and late-onset psoriasis. Proceedings of the 11th Congress of the European Academy of Dermatology and Venereology- Bologne, M.N.L. Scientific Publishing & Communication. 2003; 303-306.

Kingo K, Kõks S, Silm H, Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes and Immunity (2003) 4, 455-457.

Kingo K, Kõks S, Silm H, Vasar E. Polymorphism in the promoter region of the interleukin-20 gene - relationship to psoriasis vulgaris. JEADV 2003; 17: 378.

Silm H, Karelson M, Kingo K, Järv H, Naaber P. Küüneseenhaigusesse haigestumise sagedus Eestis. Eesti Arst 2003; 5:375-378.

Silm H, Kingo K. Esimesed kogemused psoriaasi ravimisel Daivobet salviga. Hippokrates 2003; 45:431-434.

Karelson M, Kürsa V, Kingo K, Silm H. Teleangiectasia macularis eruptiva perstans. JEADV 2002; 16: 198.

Kingo K, Kõks S, M Karelson M M, Silm H, Vasar H. Promoter polymorphism at position -592 of the interleukin-10 is not associated with early and late-onset psoriasis. JEADV 2002; 16: 291.

Silm H, Kingo K, Paasik K, Kink R. The efficacy of copper vapour laser equipment for treatment of patients with rosacea. Ann Dermatol Venereol 2002, 129: 1S615.

Silm H, Paasik K, Kingo K, Kink K. Vaskaurude laser nahahaiguste ravis. Eesti Arst 2002; 81(7): 406-410.

Silm H, Karelson M, Kingo K. Mentax 1% Cream in Treatment of Tinea Pedum and Inguinalis. Skin and Environment – Perception and Protection. 10th EADV Congress, Munich, 2001. Monduzzi Editore, 2001; 281-284.

Silm H, Kingo K, Väli M, Karelson M. Alopecia Areata in Assocation withThyroid Diseases. Pediatrtc Dermatology 2001; 18: 96.

Kingo. K, Abram. K, Silm. H. Pemphigus herpetiformis - the new pemphigus variant. JEADV 2000; 14: 195.

viimati muudetud: 04.10.2005

Curriculum Vitae (CV)
1.First Name Külli
2.Surname Kingo
3.Institution Dermatology Clinic of the Clinics of Tartu University, Department of Dermatology, University of Tartu, Raja 31, Tartu 50417, Estonia
4.Position M.D., research scientist
5.Date of birth 07.04.1972 (day.month.year)
6.Education 1978 – 1990 Tartu Secondary School No 10
1990 – 1996 University of Tartu, Faculty of Medicine (cum laude)
1997 – 2001 University of Tartu, Department of Dermatology, postgraduate student
2001 – 2005 University of Tartu, Department of Dermatology, Ph.D. student
7.Research and
professional experience		 2001 – Dermatology Clinic of the Clinics of Tartu University, M.D.
2004 – Department of Dermatology, University of Tartu, research scientist
8.Academic degree Ph.D.
9.Dates and sites of
earning the degrees		 University of Tartu, Faculty of Medicine, 10.06.2005
10.Honours/awards 1. Young Investigator's Award of the Ministry of Education for "Single nucleotide polymorphisms in the interleukin-10 and interleukin-20 genes: relationships to psoriasis", 10.12.2004.
2. The prize for Research, Medical Faculty of Tartu University for "The interleukin-20 gene polymorphisms in psoriasis", 11.10.2003.
3. PhD students award of the Center of the Molecular and Clinical Medicine for "The interleukin-20 gene polymorphisms in psoriasis", 2003.
11.Research-administrative
experience		 1. Member of the Society for Estonian Dermatologists and Venereologists
2. Member of the Estonian Society Of STD
3. Member of the Baltic Association of Dermatologists and Venereologists
4. Member of the Central and East European Dermatovenereologists Association
12.Supervised dissertations
13.Current research program The aim of scientific work is to elucidate the role of the genes of IL-10 cluster (IL-10, IL-19, IL-20 and IL-24) in predicting the risk for different chronic dermatoses.
14.Current grant funding ESF grant no. 5712: The interleukin-10 family cytokines gene polymorphisms in psoriasis.

Estonian Ministry of Education grant No. 0182128s02 (TARNH2128): Molecular and epidemiological aspects of different skin and sexually transmitted diseases in Estonia
15.List of most important publications

Kingo K, Rätsep R, Kõks S, Karelson M, Silm H, Vasar E. Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. Journal of Dermatological Science (2005) 37, 111-113.

Kingo K, Rätsep R, Kõks S, Karelson M, Silm H, Vasar E. The potential functional influence of polymorphisms of IL-20 gene in plaque psoriasis. JEADV 2005; accepted 18.07.2005.

Kõks S, Kingo K, Vabrit K et al. Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes and Immunity (2005) 6, 407-415.

Mossner R, Kingo K, Kleensang A et al. Association of TNF -238 and -308 Promoter Polymorphisms with Psoriasis Vulgaris and Psoriatic Arthritis but not with Pustulosis Palmoplantaris. J Invest Dermatol. (2005) 124, 282-284.

S. Kõks, K. Kingo, E. Vasar, H. Silm “Interleukin-19 subfamily of cytokines”, peatükk raamatus “Cytokine gene polymorphisms in multifactorial conditions”. CRC Press, ilmub 2006.

S. Kõks, K. Kingo, E. Vasar, H. Silm “Psoriasis and cytokine polymorphisms”, peatükk raamatus “Cytokine gene polymorphisms in multifactorial conditions”. CRC Press, ilmub 2006.

Kingo K, Kõks S, Nikopensius T, Silm H, Vasar E. Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes and Immunity (2004) 5, 117-121.

Kingo K. Psoriaas ja geenid. Moodne Meditsiin 2004 (nov); 18-19

Kingo K, Rätsep R, Kõks S, Karelson M, Silm H, Vasar E. Genetic influence on IL-10 expression of patients with plaque type psoriasis. JEADV 2004; 18(Sppl 2): 337.

Kõks S, Kingo K, Rätsep R, Karelson M, Silm H, Vasar E. Combined haplotype analysis of the interleukin-19 and -20 genes: relationship to plaque-type psoriasis. Genes and Immunity (2004) 5, 662–667.

Karelson M, Kürsa V., Kingo K, Silm H Teleangiectasia macularis eruptiva perstans. Proceedings of the 11th Congress of the European Academy of Dermatology and Venereology- Bologne, M.N.L. Scientific Publishing & Communication. 2003; 93-95.

Kingo K, Kõks S, Karelson M, Silm H, Vasar E. Promoter polymorphism at position-592 of the interleukin-10 is not associated with early- and late-onset psoriasis. Proceedings of the 11th Congress of the European Academy of Dermatology and Venereology- Bologne, M.N.L. Scientific Publishing & Communication. 2003; 303-306.

Kingo K, Kõks S, Silm H, Vasar E. IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes and Immunity (2003) 4, 455-457.

Kingo K, Kõks S, Silm H, Vasar E. Polymorphism in the promoter region of the interleukin-20 gene - relationship to psoriasis vulgaris. JEADV 2003; 17: 378.

Silm H, Karelson M, Kingo K, Järv H, Naaber P. Küüneseenhaigusesse haigestumise sagedus Eestis. Eesti Arst 2003; 5:375-378.

Silm H, Kingo K. Esimesed kogemused psoriaasi ravimisel Daivobet salviga. Hippokrates 2003; 45:431-434.

Karelson M, Kürsa V, Kingo K, Silm H. Teleangiectasia macularis eruptiva perstans. JEADV 2002; 16: 198.

Kingo K, Kõks S, M Karelson M M, Silm H, Vasar H. Promoter polymorphism at position -592 of the interleukin-10 is not associated with early and late-onset psoriasis. JEADV 2002; 16: 291.

Silm H, Kingo K, Paasik K, Kink R. The efficacy of copper vapour laser equipment for treatment of patients with rosacea. Ann Dermatol Venereol 2002, 129: 1S615.

Silm H, Paasik K, Kingo K, Kink K. Vaskaurude laser nahahaiguste ravis. Eesti Arst 2002; 81(7): 406-410.

Silm H, Karelson M, Kingo K. Mentax 1% Cream in Treatment of Tinea Pedum and Inguinalis. Skin and Environment – Perception and Protection. 10th EADV Congress, Munich, 2001. Monduzzi Editore, 2001; 281-284.

Silm H, Kingo K, Väli M, Karelson M. Alopecia Areata in Assocation withThyroid Diseases. Pediatrtc Dermatology 2001; 18: 96.

Kingo. K, Abram. K, Silm. H. Pemphigus herpetiformis - the new pemphigus variant. JEADV 2000; 14: 195.

last updated: 04.10.2005

[ sulge aken ]